News
23 April 2020
€102m NIB loan finances Elekta’s R&D activities for cancer care
In:
Social infrastructure
Region:
Europe
The Nordic Investment Bank and the Swedish medical equipment solutions provider Elekta AB have signed a €102 million, seven-year loan to finance R&D costs for the development of new radiotherapy solutions.
Elekta’s research programme for 2021–2025 focuses on the development of radiation therapy and radiosurgery tools, clinical treatment solutions and workflow-enhancing software systems.
Stockholm-headquartered Elekta’s R&D efforts aim to integrate interdisciplinary activities and support cooperation with clinics and academic hospitals. This intends to improve control of radiation physics, radiation dose calculation, software development and deep learning.
